Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Pharma in Focus Jobs
Beach
CRC
Latest News
Pfizer rebuffs generic competition
Litigation: Customers contacting Pfizer about a better price on its sedative Precedex tipped the pharmaco off to a generic competitor being launched, the Federal Court has heard.
Novartis drops eye drug to stem Alcon woes
Acquisitions: Novartis has decided to return the rights for Jetrea to biotech ThromboGenics in a bid to fix its stagnating eye care business.
New research may restart cardio category
Research: New research into more effective PCSK9 inhibitors and drugs that cause hearts to repair themselves is giving hope to the ailing cardio category.
Teva sells rest of women's health for USD1.4b
Acquisitions: Teva has negotiated two separate deals for its global women's health businesses which should help the Israeli pharmaco to service its debts.
Roche dragged into checkpoint inhibitor trial halts
Medicines Safety: Roche's Tecentriq has become the fourth checkpoint inhibitor caught up in the aftermath of trial deaths involving blockbuster biologic Keytruda, with the FDA now considering a class-wide safety alert.
Online GP service disrupts Rx model
Retail: An Australian online doctor website has expanded to providing online prescriptions and a pharmacy delivery service - and it says it's just getting started.
Most Popular
Job hunters in pharma declining
Employment: Employees in the Australian pharmaceutical industry are staying put in their positions with movement in the sector dropping to a three year low.
Pfizer stays on top at Prime Awards
Marketing: Pfizer managed a repeat of last year, winning four gongs at the Prime Awards in Sydney last night, while GSK and Astellas walked away with two gongs apiece.
What's a pharma boss worth
Remuneration: What can a pharma boss expect to earn in 2017 - and does gender influence pay packets at the top.
Satisfaction sliding in Aussie pharma
Workplace: Job satisfaction has declined in Australian pharma after staff cuts resulted in a leaner but less happy workforce.
Get your house in order ATO warns pharma
Taxation: The ATO has warned Australian multinational pharmaceuticals to review their businesses as a senior taskforce goes searching for unpaid taxes.
Earlier
Aust pharmacos excel at gender equity, say men
Employment: Australian pharma companies are excellent at providing equal opportunities for women, according to their male colleagues. Not all women agreed.
Bayer blood cancer drug scores quick US win
Pipeline: Bayer has added a new drug to its fledgling oncology pipeline, gaining a lightning-fast approval in the US for the follicular lymphoma candidate.
Watch out for email cyberattacks, new report advises
Industry: Corporate cyberattacks are increasing, a new report has warned, with email the channel of choice for cyber criminals.
Aust scores world first with kids cancer trial
Clinical trials: Australian children diagnosed with aggressive cancer will be the beneficiaries of a world-first clinical trial initiative to personalise treatment and improve survival rates.
AZ's Bydureon falls out of class with CV risk results
Treatment Trends: AstraZeneca's type 2 diabetes drug Bydureon has failed to show it reduced adverse cardiovascular events indicating that not all drugs in the GLP-1 class confer the prevention benefit.
Perspective
Queue for PBS listing stretches back years
With drugs waiting in the wings for PBS listing more than two and a half years after being recommended, the road to reimbursement remains a long and winding one and for some, it's a road to nowhere.
Approvals Action
Pfizer registers meningo B vax
Pfizer has registered meningococcal B vax Trumenba on the ARTG making it the second vaccine for the disease after GSK's Bexsero.
Pipeline Monitor
GSK, AZ gear up for COPD filing
Big data readouts this week saw GSK and AstraZeneca confirming they would file existing drugs in the COPD space within the next 12 months.
FREE Content
Events & Conferences
SEARCH NOW
Pharma in Focus Jobs
Ascott
lushmedia